Patent · US Active

Crispr effector system based coronavirus diagnostics

US11453907B2 · kind B2 · utility

2Cited by
6References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2020
Grant dateSep 27, 2022
Priority date
Expiry dateJun 5, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/165
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Systems and methods for rapid diagnostics related to the use of CRISPR effector systems and optimized guide sequences for detection of coronavirus, including multiplex lateral flow diagnostic devices and methods of use, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.